- Home
- RDZN vs CRBU Comparison
RDZN vs CRBU Comparison
Compare RDZN & CRBU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RDZN
- CRBU
- Stock Information
- Founded
- RDZN 2015
- CRBU 2011
- Country
- RDZN United States
- CRBU United States
- Employees
- RDZN N/A
- CRBU N/A
- Industry
- RDZN Blank Checks
- CRBU Medicinal Chemicals and Botanical Products
- Sector
- RDZN Finance
- CRBU Health Care
- Exchange
- RDZN Nasdaq
- CRBU Nasdaq
- Market Cap
- RDZN 86.1M
- CRBU 93.0M
- IPO Year
- RDZN N/A
- CRBU 2021
- Fundamental
- Price
- RDZN $1.11
- CRBU $0.73
- Analyst Decision
- RDZN Strong Buy
- CRBU Strong Buy
- Analyst Count
- RDZN 2
- CRBU 5
- Target Price
- RDZN $5.00
- CRBU $11.80
- AVG Volume (30 Days)
- RDZN 178.0K
- CRBU 976.1K
- Earning Date
- RDZN 02-12-2025
- CRBU 05-06-2025
- Dividend Yield
- RDZN N/A
- CRBU N/A
- EPS Growth
- RDZN N/A
- CRBU N/A
- EPS
- RDZN N/A
- CRBU N/A
- Revenue
- RDZN $42,893,256.00
- CRBU $9,994,000.00
- Revenue This Year
- RDZN $4.52
- CRBU N/A
- Revenue Next Year
- RDZN $53.72
- CRBU $163.34
- P/E Ratio
- RDZN N/A
- CRBU N/A
- Revenue Growth
- RDZN 2.79
- CRBU N/A
- 52 Week Low
- RDZN $0.71
- CRBU $0.72
- 52 Week High
- RDZN $6.67
- CRBU $4.85
- Technical
- Relative Strength Index (RSI)
- RDZN 48.30
- CRBU 27.65
- Support Level
- RDZN $0.96
- CRBU $0.72
- Resistance Level
- RDZN $1.38
- CRBU $1.01
- Average True Range (ATR)
- RDZN 0.13
- CRBU 0.09
- MACD
- RDZN 0.02
- CRBU -0.01
- Stochastic Oscillator
- RDZN 32.14
- CRBU 2.88
About RDZN Roadzen Inc.
Roadzen Inc is an insurance technology company on a mission to transform global auto insurance powered by advanced AI. Its clients comprise major insurers, fleets, and carmakers to small fleets, brokers, and insurance agents that use Roadzen's technology to build new products, sell insurance, process claims, and improve road safety. The company's work in telematics and computer vision has earned recognition as an AI innovator by publications such as Forbes, Fortune, and Financial Express.
About CRBU Caribou Biosciences Inc.
Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies. The company operates and manage business as one reportable operating segment, which is the business of developing a pipeline of allogeneic CAR-T and CAR-NK cell therapies. Geographically, it operates in United States and Rest of the World, of which United States derives maximum revenue.